Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
REPL
$15.04
+15.25%
REPL
· Replimune Group, Inc.
$15.04
+1.99 (+15.25%)
At close · Oct 28
Return incl. dividend (before tax)
Earnings today
Q2 2027 earnings call transcript
Going-concern doubt
— cleared Oct 28, 2026
The latest filing states the doubt was alleviated.
“As described in the Company's Annual Report on Form 10-K for the year ended March 31, 2026, substantial doubt existed about the Company's ability to continue as a going concern. The conditions that raised substantial doubt have been subsequently alleviated, as the Company raised approximately $141.0 million in net proceeds from an equity offering in August 2026.”View the 10-Q filed Oct 28, 2026
Market Cap
$1.21B
Shares
94.80M
Volume · Oct 28
3.16M
Avg daily vol (3M)
3.88M
All webcasts
Earnings call · FY2024 Q2
Replimune Group, Inc. (REPL) Q2 2024 Earnings Call
Diluted EPS
-$0.90
Net income
-$60.04M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 7, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 7, 2023 · complete as-filed document